Valuation: Provexis plc

Market Cap 22.29M 29.66M 26.62M 24.58M 41.65M 2.82B 42.16M 295M 117M 1.48B 111M 109M 4.68B P/E 2025
-22.6x
P/E 2026 -50.2x
Enterprise Value 21.39M 28.47M 25.55M 23.59M 39.98M 2.7B 40.47M 283M 112M 1.42B 107M 105M 4.49B EV / Sales 2025
7.62x
EV / Sales 2026 19.2x
Free-Float
79.16%
Yield 2025 *
-
Yield 2026 -
1 week+5.56%
Current month+2.70%
1 month+5.56%
3 months-18.80%
6 months-7.32%
Current year+5.56%
1 week 0.8
Extreme 0.8
1.1
1 month 0.8
Extreme 0.8
1.1
Current year 0.72
Extreme 0.72
1.55
1 year 0.55
Extreme 0.55
1.55
3 years 0.4
Extreme 0.4
1.55
5 years 0.4
Extreme 0.4
1.55
10 years 0.2
Extreme 0.2
1.55
Manager TitleAgeSince
Chief Executive Officer 61 -
Chief Tech/Sci/R&D Officer 53 01/01/2000
Director TitleAgeSince
Director/Board Member 61 11/11/2010
Chairman 80 01/06/2005
Director/Board Member 53 12/04/2019
Date Insider Type Main position Quantity % Market Cap. Importance
1/7/25 A Free

Chief Executive Officer

30,000,000 1.2788%
1/24/23 A Free

Chief Executive Officer

17,000,000 0.7665%
1/24/23 A Free

Chief Technology Officer

17,000,000 0.7665%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+5.56%+57.81%+64.64% 29.66M
-0.47%-0.84%+4.30%-15.28% 258B
-0.37%-1.34%+2.81%-6.19% 79.58B
+2.14%+3.45%-19.40%+12.96% 44.17B
-0.36%-1.98%+26.76%+8.92% 37.69B
-0.35%-2.84%-9.54%-12.33% 33.05B
+0.37%-2.82%+21.22%+89.96% 30.9B
-1.12%+1.14%-10.93%-7.63% 29.65B
-0.48%+1.40%-6.62%-24.64% 28.53B
+1.01%+2.92%+5.40%+7.48% 27.4B
Average +0.01%+0.47%+7.18%+11.79% 56.94B
Weighted average by Cap. -0.21%-0.26%+2.57%-3.31%

Financials

2025 2026
Net sales 1.29M 1.72M 1.54M 1.43M 2.42M 163M 2.44M 17.09M 6.79M 85.61M 6.45M 6.32M 271M 1.26M 1.68M 1.51M 1.39M 2.36M 160M 2.39M 16.72M 6.64M 83.78M 6.32M 6.18M 266M
Net income -453K -602K -541K -499K -846K -57.22M -857K -5.99M -2.38M -29.99M -2.26M -2.21M -95.11M -503K -669K -600K -554K -940K -63.55M -951K -6.65M -2.64M -33.31M -2.51M -2.46M -106M
Net Debt -708K -942K -846K -781K -1.32M -89.5M -1.34M -9.36M -3.72M -46.91M -3.54M -3.46M -149M -893K -1.19M -1.07M -985K -1.67M -113M -1.69M -11.81M -4.69M -59.17M -4.46M -4.37M -188M
Projected Income Statement - Annual - Provexis plc
Logo Provexis plc
Provexis plc is a United Kingdom-based company that develops, licenses and sells the proprietary, scientifically proven Fruitflow heart-health functional food ingredient. Fruitflow is a natural extract from tomatoes which has been shown in human trials to reduce the propensity for aberrant blood clotting, typically associated with cardiovascular disease, which can lead to heart attack and stroke. The extract is available as a spray-dried powder, and it can be included in a broad range of food, beverage and dietary supplement formats. Fruittflow is a highly concentrated form of bioactives which is lycopene-free and contains over 30 known antiplatelet compounds. The Company also offers Fruitflow+, Omega-3, and dietary supplement products which are sold directly to consumers. In addition, the Company supplies Fruitflow as an ingredient to brand owners in the food, beverage, and supplement sectors through DSM Nutritional Products’ distribution network.
Employees
2
Date Price Change Volume
28/10/26 GBX 0.9500 0.00% 1,134,467
27/10/26 GBX 0.9500 0.00% 238,260
26/10/26 GBX 0.9500 0.00% 59,039
23/10/26 GBX 0.9500 0.00% 96,539
22/10/26 GBX 0.9500 +5.56% 76,998